Epoch Investment Partners, Inc. Vertex Pharmaceuticals Inc Transaction History

Epoch Investment Partners, Inc.

$21.7 Billion
Q3 2024

A detailed history of Epoch Investment Partners, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 94,581 shares of VRTX stock, worth $43.9 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

94,581

Previous 186,029 49.16%

Holding current value

$43.9 Million

Previous $87.2 Million 49.55%

% of portfolio

0.2%

Previous 0.41%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$460.0 - $505.78 $42.1 Million - $46.3 Million	-91,448 Reduced 49.16%	94,581 $44 Million
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $2.68 Million - $3.31 Million	6,823 Added 3.81%	186,029 $87.2 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $73.3 Million - $80.2 Million	-179,710 Reduced 50.07%	179,206 $74.9 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $3.45 Million - $4.13 Million	10,059 Added 2.88%	358,916 $146 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $6.29 Million - $6.74 Million	-18,587 Reduced 5.06%	348,857 $121 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $7.53 Million - $8.43 Million	-23,953 Reduced 6.12%	367,444 $129 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $15.4 Million - $17.5 Million	54,198 Added 16.07%	391,397 $123 Million
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $33.7 Million - $37.9 Million	-117,765 Reduced 25.88%	337,199 $97.4 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $12.9 Million - $14.4 Million	-46,972 Reduced 9.36%	454,964 $132 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $96.5 Million - $120 Million	-410,761 Reduced 45.01%	501,936 $141 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $20.6 Million - $24.2 Million	92,849 Added 11.33%	912,697 $238 Million
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $89.1 Million - $112 Million	503,347 Added 159.03%	819,848 $180 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $40 Million - $44.8 Million	-220,772 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $41.4 Million - $48.8 Million	220,772 New	220,772 $44.5 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Epoch Investment Partners, Inc. with notifications on news.

Account

Epoch Investment Partners, Inc. Vertex Pharmaceuticals Inc Transaction History